The MAC 16 is a chemically induced transplantable adenocarcinoma of the colon which produces extensive weight loss in tumour-bearing mice without a reduction in overall food intake (Bibby et al., 1986) . Weight loss appears to be directly related to the size of the tumour and is apparent at small tumour masses (less than 1% of the host body weight). We have considered this tumour to be an appropriate model of human cachexia where weight loss originates from a metabolic effect of the tumour.
Summary The MAC 16 is a transplantable murine carcinoma of the colon producing extensive weight loss in tumour-bearing animals. The weight loss is proportional to the size of the tumour and occurs without a reduction in food intake when compared with non tumour-bearing control mice. Weight loss produced by the MAC 16 tumour is accompanied by hypoglycaemia which becomes more extensive as the tumour mass increases.
In order to understand the mechanism of the cachexia produced by the MAC 16 tumour the rate of substrate utilization and CO2 formation from both glucose and palmitate has been compared in vitro, with other colon carcinoma cell lines known not to produce cachexia as well as a range of murine and human tumour cell lines. The rate of glucose consumption, lactate production and CO2 formation from both glucose and palmitate is much higher for the MAC 16 than for the other tumour cells. For all cell lines in vitro the consumption of glucose exceeds that of palmitate by a factor of 103. Excessive consumption of glucose by the MAC 16 tumour may account for the hypoglycaemic effect on the host. The level of 3 oxo acid CoA transferase, an ihitiator of ketone body utilization, was found to be much lower in the MAC 16 tumour than non-involved colon. This suggests that the tumour may not be able to metabolize ketone bodies effectively.
The MAC 16 is a chemically induced transplantable adenocarcinoma of the colon which produces extensive weight loss in tumour-bearing mice without a reduction in overall food intake (Bibby et al., 1986) . Weight loss appears to be directly related to the size of the tumour and is apparent at small tumour masses (less than 1% of the host body weight). We have considered this tumour to be an appropriate model of human cachexia where weight loss originates from a metabolic effect of the tumour.
During the phase of host weight loss in mice bearing the MAC 16 tumour extensive mobilization of adipose tissue occurs with a corresponding rise in the plasma level of free fatty acids (FFA), although there is not a marked ketosis as might be expected in simple starvation (Tisdale et al., 1985) . The tumour also has a marked hypoglycaemic effect on the host. We have reduced the host weight loss produced by the MAC 16 tumour by feeding a diet with increasing proportions of energy derived from medium chain triglycerides. In addition this dietary regime produced marked reductions in tumour size, suggesting the inability of the tumour to utilize fat as an energy source The MAC tumours are a series of transplantable adenocarcinomas of the large bowel of mice from primary tumours induced by prolonged administration of 1,2-dimethyl hydrazine (Double & Ball, 1975 ] palmitic acid (0.67 p Ci ml 1 plus 3.57 j mol sodium palmitate ml -1) were added to cells (1-3 x 106ml-1) in 10ml portions in culture flasks equipped with suba seals and a centre well. At various time periods up to 24 h 0.3 ml of 3N NaOH was injected into the centre well and 0.5 ml of 2N perchloric acid was injected through the rubber cap to stop the reaction and release 14CO2 from the medium. After a further 1 h of incubation, in order to ensure complete absorption of the released 14CO2 into the alkaline solution, the contents of the centre wdowere combined with 10ml Optiphase scintillation fluid (Fisons, Loughborough) and the radioactivity determined.
The glucose consumption and lactate production were determined on separate non-radioactive incubations. Glucose was measured by the otoluidine reagent kit (Sigma Chemical Co., Dorset) and lactate levels were measured using the method of Gutman & Wahlefield (1974 
Results
The MAC 16 tumour produces extensive host body weight loss. In males almost 20% of the total body weight is lost within 30 days after tumour transplantation ( Figure 1 ) and in females as much as 33% when compared with age matched controls. Weight loss occurs even with a small tumour burden and increases with increasing weight of tumour ( Figure 2 ). The first significant loss of weight occurs around 14 days after tumour transplantation when the tumour mass is only -0.2g ( <1% of the host weight). The host weight reduction occurs without a measurable drop in food intake. Concomitant with the reduction in host weight there is also a decrease in the level of blood glucose in tumour-bearing mice with increasing time after tumour transplantation, which is significantly lower (P<0.01) than non-tumourbearing mice 21 days after tumour transplantation (Figure 3) .
The rates of glucose and palmitate oxidation and CO2 and lactate production by a range of human and murine cell lines in vitro is shown in Table I (Tisdale & Brennan, 1983) . The activity of 3-hydroxybutyrate dehydrogenase in all tissues is high enough to allow for the utilization of 3-hydroxybutyrate by metabolic oxidation. When compared with normal colon the activity is higher in the MAC 16 tumour suggesting no limitation on the conversion of 3-hydroxybutyrate to acetoacetate.
Amongst the non-involved mouse tissues the activity of 3 oxo acid CoA transferase is highest in the heart and lowest in the liver as previously reported (Fenselau & Wallis, 1974; Tisdale & Brennan, 1983 High levels of acetoacetyl CoA thiolase are found in kidney, heart and liver. The lowest level is found in the MAC 16 tumour and this activity is significantly (P<0.003) lower than normal colon. The high level of this enzyme in liver probably reflects the role of the thiolase in processes other than ketone body utilization.
Discussion
Tumour cells exhibit considerable flexibility in their ability to utilize energy producing substrates in vitro. However, a number of rapidly growing tumours exhibit high rates of aerobic glycolysis and lactate production. The AS-30D rat hepatoma cell line when supplied in vitro with glucose as the only energy source derived about 60% of the total cell ATP from glycolysis and 40% from oxidative phosphorylation (Nakashima et al., 1984) . Some tumours are unable to utilize fat as a metabolic substrate due to enzyme deficiency. Thus the poorly differentiated hepatoma 7777 exhibited low levels of fatty acyl CoA, no appreciable activity of carnitine palmitoyl transferase and fortified homogenates of the tumour were unable to oxidize palmitate (Fields et al., 1981) . In general those tumours which grow slowly and which lack the capacity for glucose phosphorylation readily oxidize fatty acids, while the high glycolysing tumours fail to oxidize fatty acids (Bloch-Frankenthal et al., 1965) . Zielke et al. (1984) have also shown that oxidation of fatty acids or ketone bodies does not contribute significantly to the energy needs of cultured mammalian cells, and that the apparent requirement for glucose is related to its role in anabolic reactions. In the present study the rate of palmitate oxidation to CO2 was only about one tenth the rate of CO2 production from glucose even in the MAC 16. This low utilization of fatty acids may explain the reduction in tumour size when the host is fed a high fat diet. Isocaloric consumption of a diet high in fat and protein and low in carbohydrate has been shown to significantly prolong the survival of MCA-sarcoma bearing rats (Demetrakopoulos & Rosenthal, 1982) and a diet high in long chain triglycerides reduced the number of B16 melanoma deposits in the lungs of C57BL/6 mice by two thirds (Magee et al., 1979) . Also starvation-induced hypoglycaemia and streptozotocin-induced diabetes has been shown to suppress the growth of Ehrlich ascites tumour in mice (Fung et al., 1985) . In the cell lines under study the ratio of lactate to CO2 production from glucose ranged from over 200 to 26. Thus, although the cultures were well aerated production of lactate from glucose appears to be the preferred metabolic reaction.
In vivo tumour architecture may play a role in the choice of metabolic substrates. Large solid tumours tend to be poorly vascularized on the inside and a large fraction is consequently hypoxic. Under conditions of low oxygen tension the mitochondiral oxidation pathway may be nonfunctional and glucose may be the only utilizable metabolic substrate, since the Embden Meyerhoff pathway is the only means of ATP production that does not require oxygen. Indeed, increased Cori cycle activity has been observed in cancer patients with progressive weight loss, showing that lactate production rates are higher in these patients (Holroyde et al., 1975) . If the glucose formed from lactate in the liver is utilized by the tumour to produce more lactate, then this represents an energy burden on the host, which has been considered responsible for the tumour-induced weight loss (Gold, 1976) .
The high glucose consumption by the MAC 16 tumour in vitro may be responsible for the hypoglycaemia in the host if the same situation occurs in vivo, although substrate utilization in vitro may have no bearing whatsoever to the situation in vivo. A tumour mass of 1 g of viable cells would consume about 11 g of glucose per day, which represents a considerable burden on the host. If the glucose was not derived from external sources and was obtained by gluconeogenesis from lactate the host would need to consume an extra 3.4 g of fat, or derive it from its adipose supply, in order to supply sufficient ATP to drive the Cori cycle. Even a small tumour burden would impose a considerable strain on the host, which may account for the rapid depletion of fat deposits in mice bearing the MAC 16 tumour.
We and others (Tisdale & Brennan, 1983; Magee et al., 1979; Williams & Matthaei, 1981) have considered the possibility of reversing the cachectic effect of certain tumours by the induction of systemic ketosis. Metabolism of ketone bodies to produce ATP requires oxygen and thus might be expected to be low in the anoxic tumour fraction. In addition the extent to which 3-hydroxybutyrate serves as a respiratory fuel is thought to be governed by the level of 3 oxo acid CoA transferase (Williamson et al., 1971) , although some tumours have acquired the enzyme acetoacetyl CoA synthetase, which enables the direct utilization of acetoacetate (Tisdale, 1984) . Levels of 3 oxo acid CoA transferase have been reported to be decreased or absent in a range of murine (Fields et al., 1981; Tisdale & Brennan, 1983) and human tumours (Fredericks & Ramsey, 1978) suggesting an impaired ability to metabolize ketone bodies. The MAC 16 is a well differentiated adenocarcinoma and enzyme activity has been compared with normal colon. On this basis MAC 16 also displays a low activity of 3 oxo acid CoA transferase and might be expected to metabolize 3-hydroxybutyrate at a reduced rate. Indeed under a dietary regime in which a high proportion of the energy is supplied as medium chain triglycerides tumour growth is inhibited in vivo without any alteration in the levels of ketone body metabolizing enzymes . These results suggest that it may be possible to differentially feed the host at the expense of the tumour.
